indication for semaglutide 💊 NEW ORAL WEGOVY® (Semaglutide) – GPhC Exam Summary, 📌 Licensed for:, ✅ BMI ≥30 kg/m², OR, ✅ BMI ≥27 kg/m² + weight-related comorbidity (e.g. T2DM, HTN, dyslipidaemia, OSA), 🥗 Must be used with:, • Semaglutide Dosing - Doctor's Advice

For example, if your BMI was 37 when you started treatment but has since fallen to 34, your healthcare provider can document that you met the BMI 35 requirement at the start of therapy

Molecular docking was performed using AutoDock Vina and MGL Tools (Trott and Olson, 2010

Rachel Suba, RD, CSSD, a Division I collegiate sports dietitian, told me at the conference that her program added a GLP-1 screening question to its standard intake, just to flag potential issues early

10.1016/j.neurot.2025.e00712 Neurotherapeutics 24 SadekM

In metabolomic profiling studies conducted in pediatric populations, including children with gastrointestinal or neurodevelopmental conditions, 3oxoglutaric acid has been consistently identified as a microbial fermentation byproduct linked to shifts in gut ecology 17,28

Abstract The glucagon-like peptide-1 receptor (GLP-1R) has broad physiological roles and is a validated target for treatment of metabolic disorders